1.Protective effect of leuprorelin particle application before laparoscopic cystectomy on ovarian reserve function in ovarian endometriosis
Chinese Journal of Biochemical Pharmaceutics 2016;36(8):55-57
Objective To study the protective effect of leuprorelin particle on ovarian reserve function applied before the laparoscopic cystectomy of ovarian endometriosis.Methods 106 patients with endometriosis treated from January 2015 to December 2015 in our hospital were selected.The subjects were divided into two groups according to the random number table, 53 cases of each group.The control group adopted the laparoscopic surgery;the observation group took the leuprorelin particle before the laparoscopic surgery.The operation condition, ovarian hormone and function were observed. Results The operation time and bleeding amount in observation group was better than control group ( P <0.05 ) .After surgery, the exhaust time between two groups had no significantly different.After surgery, the level of follicle stimulating hormone (FSH) in observation group was lower than control group; the level of estradiol (E2) in observation group was higher than control group (P <0.05); the level of luteinizing hormone (LH) between two groups had no significantly different.After surgery, the ovarian volume and antral follicle count ( AFC) in observation group was better than control group (P<0.05).Conclusion Before the laparoscopic cystectomy of ovarian endometriosis, the leuprorelin particle protects the ovarian function and morphology and has less impact in the level of hormone.
2.Study progress of insulin-like growth factor receptor type 1 gene mutation and short stature
Chinese Journal of Applied Clinical Pediatrics 2014;29(20):1528-1530
Insulin-like growth factor receptor type 1 (IGF-1 R) is the receptor cascade effect molecules of IGF signaling pathways in the hypothalamus-pituitary-growth hormone axis.In recent years,IGF-1R gene mutation of short stature case reports increased year by year,now the progress of IGF-1R gene defects in short stature for clinicians was summarized.
3.The Clinical Analysis of Serum Level of Uric Acid in 80 Hemodialysis Patients
Journal of Kunming Medical University 2013;(8):110-113
Objective To investigate the effect of serum uric acid (UA) on cardiovascular diseases in hemodialysis patients. Methods The serum level of uric acid and other laboratory indexes of 80 hemodialysis patients were detected,and the left ventricular mass index (LVMI) and left ventricular ejection fraction (LVEF) were detected by ultrasonic cardiography examination. Results According to the serum level of UA, the hemodialysis patients were divided into 2 groups:the group with high serum level of UA and the group with normal serum level of UA. There were significant differences (P<0.05) in hypertension history,the period of hypertension history, systolic blood pressure before hemodialysis between the two groups. The serum levels of UA,creatinine, triglyceride, low density lipoprotein cholesterol, C-reactive protein, brain natriuretic peptide and LVMI were significantly higher,while the serum levels of albumin,pre-albumin,high density lipoprotein cholesterol, LVEF were lower in the group with high serum level of UA than those in the group with normal high serum level of UA (P<0.05) . Furthermore, the serum levels of UA in 80 patients was positively correlated to systolic blood pressure before hemodialysis, serum creatinine, triglyceride, low density lipoprotein cholesterol, C-reactive protein, brain natriuretic peptide, and LVMI (P<0.05), while it was negatively correlated to serum albumin, pre-albumin, high density lipoprotein cholesterol and LVEF (P<0.05) . Conclusion High serum level of uric acid is associated with the onset of cardiovascular diseases in hemodialysis patients.
4.Differentiation of mesenchymal stem cells derived from human umbilical cord into cardiomyocytes
Jingling HUANG ; Shuixiang YANG
Chinese Journal of Tissue Engineering Research 2008;12(47):9367-9370
BACKGROUND:Compared with the bone marrow mesenchymal stem cells (BMSCs),cells from the umbilical cord blood (UCB)are considered"very young",and its proliferation and differentiation cannot decrease with age.Thus,cells from UCB are a great substitute of BMSCs.OBJECTIVE:To observe the characteristics of in vitro differentiation of UCB-MSCs into cardiomyocytes.DESIGN,TIME AND SETTING:The observational experiment was performed at the Beijing Sijitan Hospital from March 2005 to February 2007.MATERIALS:Cells from UCB were collected from healthy arturients after signing the informed consent.METHODS:Mononuclear cells were isolated to further harvest MSCs.At the third passage,CD34,CD44 and CD90 were measured using immunofluorescence flow cytometry.After 4 weeks of 5-azacitidine treatment,myosin heavy chain,GATA4 and troponin 1 were identified using immunohistochemistry and reverse transcription-polymerase chain reaction.MAIN OUTCOME MEASURES:β-myosin heavy chain,GATA4 and troponin I expression.RESULTS:UCB-MSCs showed a fibrolast-like morphology,clonally expanded after 5-azacitidine reatment.The immunophenotype of these clonally expanded cells is consistent with that reported for BMSCs.Immunohistochemistry and reverse transcription-polymerase chain reaction showed β-myosin heavy chain,GATA4 and troponin I expression.CONCLUSION:UCB-MSCs differentiate into cardiomyocyte-like cells,which have the characteristics of cardiomyocytes.
5.Early changes of endothelin and nitric oxide in patients with acute brain injury
Chinese Journal of Trauma 2001;17(5):269-271
Objective To investigate the early changes and clinical significance of plasma endothelin(ET) and nitric oxide(NO) in patients with acute brain injury. Methods The plasma ET and NO concentration at 1 day after injury were checked with radioimmunoassay and Green method in 48 cases of acute brain injury, in 42 cases of non-brain injury and in 38 healthy volunteers. Results The early plasma concentrations of ET and NO were (109.73±12.61) ng/Lf and (92.82±18.21) μmol/L, respectively, in 48 cases of acute cerebral injury, which were higher than those in the non-brain injury group[(67.90±11.33) ng/L and (52.66±12.82) μmol/L, respectively, P<0.01] and in the normal control group [(50.65±17.12)ng/L and (36.12±12.16) μmol/L, respectively, P<0.001]. The amounts of ET and NO in the patients with severe brain injury were (116.18±18.12) ng/L and (108.19±13.28) μmol/L, respectively, which were significantly higher than that of the moderate brain injury group[(92.33±16.32) ng/L and (76.38±12.71) μmol/L, respectively, P<0.01].The early levels of ET and NO were negatively related to the GCS scores of the patients with acute brain injury. The amounts of ET and NO were (126.23±15.23)ng/l and (118.18±10.12) μmol/L, respectively, in the patients with subdural hematomas, which were significantly higher than those in the patients with epidural hematomas [(81.13±12.37) ng/L and(68.02±13.18) μmol/L, respectively, P<0.01]. The stable plasma concentrations of ET and NO at 14 days after injury in the patients with acute brain injury and with non-brain injury were similar to that in the normal controls. Conclusions ET and NO are related to the pathophysiological process in the early period of acute brain injury, and the values of ET and NO correlate positively with the clinical manifestations. The changes of plasma ET and NO can be regarded as important indexes to diagnose the severity of acute brain injury.
6.The clinical observation on the effect of gemcitabine plus oxaliplatin in treatment of relapsed or refractory non-Hodgkin's lymphoma
Chinese Journal of Primary Medicine and Pharmacy 2011;18(17):2321-2322
Objective To analyze the clinical efficacy of gemcitabine plus oxaliplatin in treatment of relapsed or refractory non-Hodgkin's lymphoma(NHL).Methods 39 cases with relapsed or refractory NHL were treated by gemcitabine and oxaliplatin combination chemotherapy. After three cycles, its efficacy and adverse reactions were observed. Serum lactate dehydrogenase(LDH) concentration was detected before and after treatment and all the patients were followed up. Results The rate CR was 11cases (28. 1% ), PR 16cases (41.03%), NC 7cases (17.95%),PD 5cases(12.82%).Thetotalresponserate(CR+PR) was 69. 23%. Conclusion Gemcitabineand oxaliplatin combination chemotherapy in treatment of patients with relapsed or refractory NHL was safe and effective.
7.Progress on ADAM9 in tumors
International Journal of Surgery 2008;35(8):549-552
ADAM9, a member of ADAM family, plays an important role in development of many human diseases especially neoplasms as its metaUoproteinases activity and the ability of combining with integrins. This might help us find new therapeutic targetpoints and therefore offer new therapeutic approaches.
8.Research progress of glioma stem cells and the related signal transduction pathways
Cancer Research and Clinic 2013;25(12):853-855
Gliomas harbor a small population of cells termed glioma stem-like cells (GSC),which have the ability to undergo self-renewal and initiate tumorigenesis.GSCs are resistant to a wide variety of chemotherapeutic agents and possess a remarkable ability to recover from cytotoxic therapy.Furthermore,GSCs play a crucial role in RT failure,as tumors surviving RT are enriched in GSCs.Therefore,an alternative strategy involving selective targeting of this functionally distinct chemo-and radiation resistant small group of GSCs rather than the bulk of the tumor may be more successful in treating this deadly disease.GSC exhibit various alterations to signaling pathway activity,which are associated with self-renewal and neoplastic proliferation.These altered pathways may represent possible targets for GSC.
9.Driver genes and targeted drugs in lung cancer
Journal of International Oncology 2017;44(1):53-56
With the development of molecular biology of cancer,molecular targeted therapy which tar-geted the driver genes in lung cancer has become an inevitable part of the treatment of advanced lung cancer. The most successful examples of targeted therapy are targeting epidermal growth factor receptor (EGFR)and anaplastic lymphoma kinase (ALK).More and more driver genes have been discovered,including ROS1 gene fusion,fibroblast growth factor receptor 1 amplification,KRAS,BRAF,PIK3CA gene mutation and so on.It is meaningful for guiding the treatment of lung cancer that defines the mutation incidence and clinical significance of driver genes in lung cancer.
10.Therapeutic effect of cardiopulmonary resuscitation and nursing intervention on patients with massive ;myocardial infarction complicated cardiac arrest
Chinese Journal of cardiovascular Rehabilitation Medicine 2017;26(1):116-119
Objective:To explore therapeutic effect of cardiopulmonary resuscitation (CPR) and nursing intervention on patients with massive myocardial infarction (MMI) complicated cardiac arrest (CA) .Methods :A total of 100 MMI + CA patients ,who were treated in our hospital from Jan 2014 to Dec 2014 ,were selected .According to CA‐to‐CPR time ,patients were divided into >6min group (n=12) ,4~6min group (n=21) ,1~3min group (n=33) and <1min group (n=34) .CPR result ,patient outcome ,and satisfaction of patients and their family's on first aid and nursing were observed and compared among all groups .Results:Number of successful revived cases was 0 ,4 ,18 and 28 cases in > 6 min group ,4~6min group ,1~3min group and <1min group respectively ,there were 50 cases successfully revived in total .Compared with >6 min group ,4~6min group ,there were significant rise in success rates of CPR (0% ,19.05% vs .54.55% ,82.35% ) in 1~3min group and <1min group ,P<0.05 or <0.01. Cure rate was 43 (86. 00% ) in successful revived patients ,including 15 cases from 1~3min group and 28 cases from <1min group .Patient′s satisfaction was 66.67% ,90.48% ,93.94% and 97.06% in >6 min group ,4~6min group ,1~3min group and <1min group respectively ,and total satisfaction rate was 92.00% .No medical dispute occurred . Conclusion:CPR timing is the key of emergency rescuing patients with massive myocardial infarction complicated cardiac arrest ,and function of nursing intervention is great because it enhances rescue effect .

Result Analysis
Print
Save
E-mail